A shotgun approach including peptide-based OFFGEL-isoelectric focusing (IEF) fractionation has been developed with the aim of improving the identification of platinum-binding proteins in biological samples. The method is based on a filter-aided sample preparation (FASP) tryptic digestion under denaturing and reducing conditions of cisplatin–, oxaliplatin–, and carboplatin–protein complexes, followed by OFFGEL-IEF separation of the peptides. Any risk of platinum loss is minimized throughout the procedure due to the removal of the reagents used after each stage of the FASP method and the absence of thiol-based reagents in the focusing buffer employed in the IEF separation. The platinum–peptide complexes stability after the FASP digestion and ...
A method based on the coupling of high resolution size-exclusion liquid chromatography using a polym...
Shotgun proteomics originated as a strategy to identify proteins in complex protein mixtures, but it...
Although genomic DNA is the primary target of anticancer platinum-based drugs, interactions with pro...
A method for the analysis of Pt–protein complexes in biological samples, previously subjected to cis...
In this work a 2D electrophoretic separation procedure able to maintain the integrity of platinum–pr...
The judicious use of cis-Pt as an intravenously administrable Pt(II) drug for chemotherapy requires ...
The judicious use of cis-Pt as an intravenously administrable Pt(II) drug for chemotherapy requires ...
Platinum drugs have become one of the most important kinds of chemotherapy agents, and the interacti...
The characterization of the interaction of platinum drugs with proteins has been previously performe...
To further explore the binding chemistry of cisplatin (cis-Pt(NH3)2Cl2) to peptides and also establi...
The interaction of the antitumor drug cisplatin with insulin was studied using a top-down mass spect...
The analysis of the complexes between metal-based chemotherapeutic drugs and proteins in biological ...
Cisplatin is a potent anti-cancer drug, which functions by cross-linking adjacent DNA guanine residu...
Protein–cisplatin interactions lie at the heart of both the effectiveness of cisplatin as a therapeu...
A method based on the coupling of high resolution size-exclusion liquid chromatography using a polym...
A method based on the coupling of high resolution size-exclusion liquid chromatography using a polym...
Shotgun proteomics originated as a strategy to identify proteins in complex protein mixtures, but it...
Although genomic DNA is the primary target of anticancer platinum-based drugs, interactions with pro...
A method for the analysis of Pt–protein complexes in biological samples, previously subjected to cis...
In this work a 2D electrophoretic separation procedure able to maintain the integrity of platinum–pr...
The judicious use of cis-Pt as an intravenously administrable Pt(II) drug for chemotherapy requires ...
The judicious use of cis-Pt as an intravenously administrable Pt(II) drug for chemotherapy requires ...
Platinum drugs have become one of the most important kinds of chemotherapy agents, and the interacti...
The characterization of the interaction of platinum drugs with proteins has been previously performe...
To further explore the binding chemistry of cisplatin (cis-Pt(NH3)2Cl2) to peptides and also establi...
The interaction of the antitumor drug cisplatin with insulin was studied using a top-down mass spect...
The analysis of the complexes between metal-based chemotherapeutic drugs and proteins in biological ...
Cisplatin is a potent anti-cancer drug, which functions by cross-linking adjacent DNA guanine residu...
Protein–cisplatin interactions lie at the heart of both the effectiveness of cisplatin as a therapeu...
A method based on the coupling of high resolution size-exclusion liquid chromatography using a polym...
A method based on the coupling of high resolution size-exclusion liquid chromatography using a polym...
Shotgun proteomics originated as a strategy to identify proteins in complex protein mixtures, but it...
Although genomic DNA is the primary target of anticancer platinum-based drugs, interactions with pro...